-
-
-
-
-
-
-
Daré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update
-
-
-
-
-
-
-
UPDATE: H.C. Wainwright Starts Dare Bioscience (DARE) at Buy, $5 PT
-
-
-
-
-
-
-
Daré Bioscience Announces Feature Presentation at the15th US-Japan Symposium on Drug Delivery Systems
-
-
-
-
-
-
-
Daré Bioscience Announces Appointment of Dr. William H. Rastetter as Chairman of the Board of Directors
-
-
-
-
-
-
-
Daré Bioscience, Inc. to Present an Overview of Novel Intra-Vaginal Ring (IVR) Technologies at the Partnership Opportunities in Drug Delivery (PODD) Meeting Held in Boston, MA October 17th – 18th
-
-
-
-
-
-
-
Dare Bioscience (DARE) to Acquire Product to Address Vulvar and Vaginal Atrophy in Hormone Receptor-Positive Breast Cancer Patients
-
-
1,186,489 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

